Intelligent Bio Solutions Inc. INBS
Medical/Dental Instruments · IPO 2020 · data as of November 13, 2026
Intelligent Bio Solutions Inc. (INBS) is a healthcare company listed in the US with a market value of about $6M. In the twelve months to September 30, 2026 it had revenue of $4M and net income of -$12M, a net margin of -269.3%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 16% a year, a 5-year average ROIC of -155%.
About Intelligent Bio Solutions
Intelligent Bio Solutions is listed in the US and classified in medical/dental instruments, IPO year 2020. Revenue went from $188744 in 2020 to $4M in 2026, growth of about 67.8% a year. It was profitable in 0 of the last 7 years in our data. Its share count rose by 17492% over three years (dilution for shareholders).
Score: 1.6 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $4M | $3M | $3M | $1M | $437146 | $2M | $188744 |
| Net income | -$12M | -$12M | -$11M | -$10M | -$11M | -$8M | -$7M | -$3M |
| Free cash flow | — | -$12M | -$10M | -$10M | — | — | — | — |
| EPS (diluted) | $-6.38 | $-8.44 | $-20.04 | $-63.80 | $-1270.00 | $-1359.59 | $-81.60 | $-44.40 |
| Net margin | -269.3% | -294.9% | -346.2% | -326.4% | -845.9% | -1900.1% | -355.3% | -1676.2% |
| ROIC | — | -135.9% | -257.4% | -88.3% | -193.8% | -99.4% | -29.2% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Intelligent Bio Solutions pay a dividend?
Not currently.
Is Intelligent Bio Solutions a good stock to buy?
We do not give buy or sell advice. Intelligent Bio Solutions scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.